Phase 2 Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have signed a written consent form agreeing to take part in the study
- People who have been diagnosed with high or very high risk prostate cancer, confirmed by a laboratory examination of tissue
- People who have completed radical local treatment for their prostate cancer
- People whose local treatment was completed within 3 months before joining the study
- People who are generally well enough to carry out daily activities, rated on a standard scale from 0 (fully active) to 2 (up and about more than half the day) (confirm with trial site)
- People aged 18 years or older
- People who had no signs of cancer spread shown on imaging scans within 28 days before entering the study
- People whose testosterone levels are at a very low "castrate" level (below 50 ng/dL or 1.7 nmol/L)
- People whose bone marrow, liver, and kidneys are functioning well enough to meet specific blood and laboratory test thresholds (confirm with trial site for exact values)
- Men of reproductive age who are willing to use two forms of contraception at the same time during the trial
Who may not be able to join:
- People whose imaging scans confirm that cancer has spread to distant parts of the body
- People who are not willing or able to use an effective method of contraception
- People who do not consent to taking part in the study
- People who have a blockage in their urinary tract or fluid build-up in the kidneys (hydronephrosis)
- People who are currently receiving any other cancer treatment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 48322789339
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Treatment effectiveness
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.